2021
Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents
CURILLOVA, Jana, Maria PECHACOVA, Tereza PADRTOVÁ, Daniel PECHER, Sarka MASCARETTI et. al.Základní údaje
Originální název
Synthesis and Critical View on the Structure-Activity Relationships of N-(Substituted phenyl)-/N-Diphenylmethyl-piperazine-Based Conjugates as Antimycobacterial Agents
Autoři
CURILLOVA, Jana (703 Slovensko), Maria PECHACOVA (703 Slovensko), Tereza PADRTOVÁ (203 Česká republika, domácí), Daniel PECHER (703 Slovensko), Sarka MASCARETTI (203 Česká republika), Josef JAMPÍLEK (203 Česká republika), Ludmila PASKOVA (703 Slovensko), Frantisek BILKA (703 Slovensko), Gustav KOVAC (703 Slovensko) a Ivan MALIK (703 Slovensko, garant)
Vydání
Applied sciences, Basel, MDPI, 2021, 2076-3417
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30107 Medicinal chemistry
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.838
Kód RIV
RIV/00216224:14160/21:00124261
Organizační jednotka
Farmaceutická fakulta
UT WoS
000752599900001
Klíčová slova anglicky
drug development; N-arylpiperazines; mycobacteria; electronic properties; lipophilicity; cytotoxicity; structure-activity
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 3. 2022 13:39, PharmDr. Tereza Padrtová, Ph.D.
Anotace
V originále
This research focused on a three-step synthesis, analytical, physicochemical, and biological evaluation of hybrid molecules 6a-g, containing a lipophilic 3-trifluoromethylphenyl moiety, polar carbamoyloxy bridge, 2-hydroxypropan-1,3-diyl chain and 4-(substituted phenyl)-/4-diphenylmethylpiperazin-1-ium-1-yl fragment. The estimation of analytical and physicochemical descriptors (m/z(measured) via HPLC-UV/HR-MS, log epsilon(2 (Ch-T)) from UV/Vis spectrophotometry and log k(w) via RP-HPLC) as well as in vitro antimycobacterial and cytotoxic screening of given compounds were carried out (i.e., determination of MIC and IC50 values). These highly lipophilic molecules (log k(w) = 4.1170-5.2184) were tested against Mycobacterium tuberculosis H37Ra ATCC 25177 (Mtb H37Ra), M. kansasii DSM 44162 (MK), M. smegmatis ATCC 700084 (MS), and M. marinum CAMP 5644 (MM). The impact of the 6a-g set on the viability of human liver hepatocellular carcinoma (HepG2) cells was also investigated. 1-[2-Hydroxypropyl-{(3-trifluoromethyl)- phenyl}carbamoyloxy]-4-(3,4-dichlorophenyl)piperazin-1-ium chloride (6e) and 1-[2-hydroxy- propyl-{(3-trifluoromethyl)phenyl}carbamoyloxy]-4-(4-diphenylmethyl)piperazin-1-ium chloride (6g) most effectively inhibited the growth of Mtb H37Ra (MIC < 3.80 mu M). The substance 6g also showed interesting activity against MM (MIC = 8.09 mu M). All obtained data served as input values for structure-activity relationship evaluations using statistical principal component analysis. In fact, the toxicity of both 6e (IC50 = 29.39 mu M) and 6g (IC50 = 22.18 mu M) in HepG2 cells as well as selectivity index (SI) values (SI < 10.00) prevented to consider these promising antimycobacterials safe.